Skin Resurfacing denials: 41.7% overturned by independent reviewers
In 36 California IMR decisions from 2002 to 2025, reviewers overturned the plan 15 times (41.7%). In the last five years: 75.0% of 4. Denials reach IMR only when a member appeals all the way; read the caveats below before generalising.
By diagnosis
| Diagnosis category | Decisions | Overturned | Last 5 years |
|---|---|---|---|
| Skin Disorders | 25 | 44.0% | 100.0% of 3 |
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2022 | 3 | 100.0% |
| 2025 | 1 | 0.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 13 | 53.8% | 41.7% |
| Prior therapies failedThe findings mention treatments that were tried without adequate response. | 4 | 75.0% | 41.7% |
| Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial). | 3 | 0.0% | 41.7% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for surgical repair of facial lesions and removal of facial cysts. Findings: The physician reviewer found that Gallagher and colleagues note that in the dermatological use of intralesional triamcinolone in the treatment of acne, that observed skin atrophy rates are extremely low, but they are long lasting when …”
“The physician reviewer found that The patient has requested authorization and coverage for (1) a referral to a skin laser specialist, (2) a 585-nm flashlamp pumped pulsed dye laser/CO2 laser specific for scars, and (3) a higher dosage of Kenalog 40 mg. Jin and colleagues report that the management of hypertrophic scars and keloids remains a therapeutic challenge, and that …”
“Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for Integra bilayer matrix wound dressing as a component of the enrollee’s debridement and wound vacuum placement procedure to the left foot. Medical literature explain, “First developed for coverage of burn wounds, Integra is a synthetic acellular dermal regeneration template that provides a base for revascularization and neodermal …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Skin Resurfacing denials overturned?
In 36 California IMR decisions from 2002 to 2025, reviewers overturned the plan 15 times (41.7%). In the last five years: 75.0% of 4.
What did the reviewers' findings mention in overturned cases?
The table on this page counts keyword matches in the findings: prior therapies tried, contraindications, guidelines cited, published evidence, whether the records supported the request. They describe what the findings say, not why the case was decided.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but the reasoning is the same kind: criteria, documentation and alternatives. Use the findings as a guide to what to document.
Related: California appeal rights · California external-review reversal rate · The levers library · CSV
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.